Healthcare

Research and innovation addressing today's greatest health challenges

IBM Research and The Michael J. Fox Foundation Develop Modeling Methodology to Help Understand Parkinson’s Disease Using Machine Learning

In collaboration with The Michael J. Fox Foundation for Parkinson’s Research, our team of researchers at IBM is aiming to develop improved disease progression models that can help clinicians understand how the disease progresses in relation to the emergence of symptoms, even when those patients are taking symptom-modifying medications.

Continue reading

AI Could Help Enable Accurate Remote Monitoring of Parkinson’s Patients

In a paper recently published in Nature Scientific Reports, IBM Research and scientists from several other medical institutions developed a new way to estimate the severity of a person’s Parkinson’s disease (PD) symptoms by remotely measuring and analyzing physical activity as motor impairment increased. Using data captured by wrist-worn accelerometers, we created statistical representations of […]

Continue reading

New Macromolecule Could Hold Key to Reversing Antibiotic Resistance

To address the challenge of antibiotic resistance, scientists from IBM and the Agency for Science, Technology and Research and the Singapore-MIT Alliance for Research and Technology have published new findings in Advanced Science, which unveil the effectiveness of a new polymer in the fight against resistant bacteria.

Continue reading

How chronic pain reshapes our brain activity

The process of understanding and managing chronic pain is complex, because everyone’s experience with pain is unique.  In the United States, at least 116 million U.S. adults are burdened by chronic pain, with an economic cost of well above 500 billion per year[1]. And yet, as pervasive as it is, we’ve never had a way […]

Continue reading

Novel Microfluidic Method for Microscale Bio Separations

Joint research by our group at IBM Research Europe in Zurich and collaborators at Technion, Israel, has led to a new method for separation of particles and molecules from small volume samples. The technique exploits differences in diffusivity – a molecular property which correlates well with size. We are currently adapting the method for rapid […]

Continue reading

IBM Releases Novel AI-Powered Technologies to Help Health and Research Community Accelerate the Discovery of Medical Insights and Treatments for COVID-19

IBM Research is making available multiple novel, free resources to help healthcare researchers, doctors and scientists around the world accelerate COVID-19 drug discovery.

Continue reading

The potential benefits of AI for breast cancer detection

A new study in JAMA Network Open highlights how AI can improve the accuracy of breast cancer screenings in combination with assessments from radiologists.

Continue reading

AI Can Predict your Age Based on Your Microbiome

The human microbiome consists of a community of trillions of micro-organisms, such as bacteria, fungi, viruses, and live all over the body including on the skin, in the mouth and along the digestive tract. A balanced microbiome is important for an individual’s health and wellbeing, including proper functionality the digestive and immune systems. The human […]

Continue reading

Helping Advance Huntington’s Disease Research by Using AI to Map the Human Brain

In a new study, IBM and CHDI researchers studied the relationship between the pace of subtle cognitive decline in patients before full-fledged symptoms and their brain activity, as shown by a functional MRI. The results demonstrate that measuring the potential progression of HD could eventually be done from a single brain scan, acquired in one visit.

Continue reading

Dark Matter Matters: AI Makes DNA Dark Matter Useful

What is the minimal description that captures a space? Asking a mathematician’s basic question of a  biological dataset reveals interesting answers about biology itself. This summarizes our underlying approach to subtyping hematological cancer. Disease subtyping is a central tenet of precision medicine, and is the challenging task of identifying and classifying patients with similar presentations […]

Continue reading

Helping to Untangle Cancer Drug Resistance with Data

Why do targeted cancer therapies often fail? We have acquired so much more understanding about cancer in the last fifty years than in the last five thousand years. Approaches to patient treatments have dramatically changed, and statistics show significant improvement in patient response and outcomes to therapy in the last half a century [1]. Yet […]

Continue reading

Novel AI tools to accelerate cancer research

At the 18th European Conference on Computational Biology and the 27th Conference on Intelligent Systems for Molecular Biology, IBM will present significant, novel research that led to the implementation of three machine learning solutions aimed at accelerating and guiding cancer research.

Continue reading